Adage Capital Partners
AMAG

Adage Capital Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Adage Capital Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-293,200
Closed -$10.2M – 759
2016
Q4 		$10.2M Sell
293,200
-1,925,000
-87% -$57.5M 0.03% 528
2016
Q3 		$54.4M Sell
2,218,200
-350,000
-14% -$8.75M 0.15% 178
2016
Q2 		$61.4M Buy
2,568,200
+316,393
+14% +$7.25M 0.17% 163
2016
Q1 		$52.7M Sell
2,251,807
-350,000
-13% -$8.31M 0.14% 181
2015
Q4 		$78.5M Buy
2,601,807
+603,000
+30% +$19.5M 0.21% 139
2015
Q3 		$79.4M Buy
1,998,807
+1,048,807
+110% +$65.1M 0.22% 128
2015
Q2 		$65.6M Sell
950,000
-950,000
-50% -$59.8M 0.16% 174
2015
Q1 		$104M Sell
1,900,000
-1,896,592
-50% -$90.4M 0.25% 110
2014
Q4 		$162M Hold
3,796,592
– – 0.4% 65
2014
Q3 		$121M Hold
3,796,592
– – 0.3% 85
2014
Q2 		$78.7M Hold
3,796,592
– – 0.2% 142
2014
Q1 		$73.5M Hold
3,796,592
– – 0.2% 152
2013
Q4 		$92.2M Hold
3,796,592
– – 0.24% 120
2013
Q3 		$81.5M Sell
3,796,592
-288,738
-7% -$6.82M 0.23% 126
2013
Q2 		$90.9M Buy
+4,085,330
New +$90M 0.28% 96

Other funds holding AMAG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners's AMAG Position: Q1 2017 in Review

Adage Capital Partners sold out of AMAG Pharmaceuticals (AMAG) in Q1 2017, closing a stake of 293,200 shares — an estimated $10.2M sold.

Adage Capital Partners first reported a position in AMAG in Q2 2013 and held it in 15 quarters. The position peaked at $162M in Q4 2014. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2017.

  • Adage Capital Partners reported no remaining AMAG Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Adage Capital Partners sold 293,200 AMAG Pharmaceuticals shares in Q1 2017, an estimated $10.2M.
  • Adage Capital Partners first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • Adage Capital Partners's AMAG Pharmaceuticals position peaked at $162M in Q4 2014.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2017.

Based on Adage Capital Partners's 13F filing for Q1 2017, filed 15 May 2017.